Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0034186 (pyelonephritis)
 6,144 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Renal allografts were transplanted into 20 dogs (12 beagles, eight mongrels) following a prescribed protocol for pre-transplantation blood transfusions and kidney exchange. Immunosuppressive therapy (azathioprine and prednisone) was modified as needed for each dog. Seven of the beagle dogs survived for 1 year and were then euthanized; all other dogs died or were euthanized prior to 1 year post-transplantation. Graft rejection and renal failure were the greatest causes of mortality. Renal lesions which contributed to the death of some animals included renal vein thrombosis, nephrosis, and pyelonephritis. Inflammation of the lower respiratory tract (bronchitis, pneumonia, and pleuritis) was a contributory cause of death in some dogs. Cystitis and ureteritis occurred in almost half of the dogs. Prostatitis was seen in six of the 16 male dogs. Adrenal cortical atrophy, parathyroid gland hyperplasia, and bone marrow hypocellularity were seen in a majority of the dogs which survived 1 year.
 ...
PMID:Lesions in dogs following renal transplantation and immunosuppression. 355 16

The incidence of morphological and functional changes of the upper urinary passages and the kidneys obtains 78% in chronic prostatitis. The predominant localisation of the inflammation in the prostate and of the changes on the upper urinary passages and the kidneys on the same side confirms the importance of the chronic prostatitis in the pathogenesis of pathological conditions of the uropoetic system. Chronic pyelonephritis and nephrolithiasis can be proved in 24.5 and 78% of the patients with chronic prostatitis, respectively. Thus, the incidence of these diseases is significantly higher in patients with chronic prostatitis than in patients without such a disease. In 47% of the patients with chronic pyelonephritis and nephrolithiasis a latent chronic prostatitis can be proved, when an exact diagnosis was made.
 ...
PMID:[Condition of the kidneys and upper urinary tract in patients with chronic prostatitis]. 355 32

A hospital-based case-control study of 153 multiple myeloma (MM) cases and 459 controls was conducted to evaluate the hypothesis that chronic or frequent infections or allergic and autoimmune diseases might be of higher prevalence in individuals who develop MM. Information was obtained by direct interviews of subjects. Controls were matched to cases on age, sex, race, and hospital. "Immune-stimulating conditions" included chronic infections such as pyelonephritis, urinary tract infections (UTIs), prostatitis, rheumatoid arthritis and other collagen vascular diseases, allergies, bronchitis, tuberculosis, cholecystitis, diverticulitis, and osteomyelitis. The overall odds ratio (OR) (odds of history of immune-stimulating conditions in cases versus controls) was 0.4 (95% confidence interval = 0.3-0.7) which suggested that cases had significantly less immune-stimulating conditions than did controls. The exposure rate for these conditions was high for cases (0.7) as well as for all control groups (0.8). These findings suggest that immune-stimulating conditions alone are not the causative factor in the etiology of MM, though they may play a role in the predisposed individual.
 ...
PMID:Role of immune stimulation in the etiology of multiple myeloma: a case control study. 381 65

Aztreonam was administered to a total of 681 patients with urinary tract infections due to susceptible gram-negative bacteria; 56 patients received a single 1-g intramuscular dose for acute uncomplicated cystitis, and 625 patients received multiple parenteral doses (usually a five-day course of 1 g two or three times daily) for a variety of urinary tract infections, including pyelonephritis, cystitis, prostatitis, and epididymitis. Microbiologic cure was achieved in 84% of patients in the single-dose study and in 85% of patients in the multiple-dose studies. In the latter studies the microbiologic cure rates for infections with Escherichia coli, the Klebsiella-Enterobacter-Serratia group, and Pseudomonas aeruginosa were 87%, 90%, and 76%, respectively. In a comparative study of aztreonam and cefamandole, the overall microbiologic cure rates were 89% and 80%, respectively. Of the 625 patients receiving multiple-dose therapy, 149 had urinary tract infections due to multiply drug-resistant bacteria; among these patients the microbiologic cure rate was 93%. Aztreonam constitutes effective therapy for urinary tract infections due to susceptible gram-negative bacilli.
 ...
PMID:Summary of worldwide clinical trials of aztreonam in patients with urinary tract infections. 390 36

A statistical study was performed on new outpatients. The total number of new outpatients in 1984 was 6,890 (male: 4,381, female: 2,509) and the male to female ratio was was 1.75:1. They had urogenital diseases definitely diagnosed (5,925), indefinitely diagnosed (325), normal (282), and diseases other than urogenital (358). Thirty percent of the outpatients were referred to by other sources. The number of operations on new outpatients was 191, circumcision, resection of condyloma and vasectomy were representative. The peak of the age distribution was in the thirties for males and in the twenties for females. For the first time in Japan, we treated renal and upper ureteral stones using Extracorporeal Shock Wave Lithotripsy (ESWL) on September 1st 1984. The results of ESWL at our hospital have been satisfactory. A statistical study was made on new outpatients according to the international disease classification. There were 94 malignant (urogenital) tumors (1.5%). The major diseases of the new outpatients were cystitis (acute or chronic: 22.8%), prostatitis (17.0%), upper urinary tract stone (12.9%), benign prostatic hypertrophy (10.1%). In males the major diseases were prostatitis, benign prostatic hypertrophy, upper urinary tract stone, balanoposthitis, gonorrhea, and in female they were cystitis, upper urinary tract stone, pyelonephritis, renoptosis. We conclude that out hospital plays a major role as a private urological hospital.
 ...
PMID:[Clinical statistics on outpatients at the Urological Clinic of Higashi Sapporo Sanjukai Hospital in 1984]. 409 Nov 23

During a one-year morbidity survey of urinary tract diseases in general practice 741 cases were diagnosed. Only about half of all the patients with symptoms of urinary tract infection had significant bacteriuria. In young women urinary tract infections and symptoms from the urinary tract without bacteriuria-in particular urethritis-were found to predominate. In middle-aged women, the urinary tract symptoms were ascribed increasingly to genital prolapse, while incidence of urolithiasis was the highest in any group, and urinary tract infections became less frequent. The prevalence of urinary tract infection showed another increase in elderly women, and recurrent/chronic pyelonephritis, which occurs with a steadily increasing prevalence throughout all age groups, became common.In younger male urological patients diseases with symptoms of urinary tract infection without bacteriuria were predominant, whereas prostatitis and urinary tract infections were less frequent. In middle-aged men, urolithiasis was especially frequent, while an increasing proportion of elderly men had prostatic hypertrophy, urinary tract infections, and recurrent/chronic pyelonephritis.
 ...
PMID:Epidemiology of urinary tract diseases in general practice. 418 93

In this study, 63 patients with various urinary tract infections were treated with cefotaxime in different dosages. They were aged from 10 to 82 years (mean: 59). The cases included 33 cystitis, 25 pyelonephritis, 4 chronic prostatitis and 1 orchiepididymitis. 85 strains of enterobacteria were identified: 20 E. coli, 2 Citrobacter freundi, 5 Proteus mirabilis, 12 indole positive Proteus, 1 Providentia, 11 Klebsiella, 3 Enterobacter cloacae and 31 Serratia marescens and liquefaciens. 80 of these strains had MIC less than or equal to 1 mcg/ml (median: 0,12 mcg/ml). More than 2/3 of the patients were treated with a daily dose of 1.50 to 2 g, and 52 (median: 0.12 mcg/ml). More than 2/3 of the patients results showed 43 cures (9 of these with reinfection) and 20 relapses. Isolated enterobacteria strains were sensitive to cefotaxime in patients with recurrence. Relapses were due to underlying urological pathology. Among reinfection organisms, only one, an Enterobacter cloacae, was resistant to cefotaxime. The clinical, local, systemic and biological tolerance was good. Cefotaxime has been very effective in the treatment of severe urinary tract infections, especially in chronic pyelonephritis and cystitis, at an average daily dose of 2 g.
 ...
PMID:[Clinical evaluation of cefotaxime at various dosage levels in urinary tract infections (author's transl)]. 625 7

Cefotiam, a new broad-spectrum cephalosporin was used for the treatment of 30 cases of urinary-tract infections (UTI). Patients, 20 females, 10 males were between 23 and 76 years old. UTI were 17 cystitis, 9 pyelonephritis and 4 prostatitis. Bacteria isolated from urine were : 24 E. Coli, 3 Proteus mirabilis, 1 Providencia, 3 Klebsiella, 3 Enterobacter, 2 Serratia, 1 Staphylococcus coagulase--, DNAse--. MIC's of cefotiam ranged from 0.003 to 32 micrograms/ml (median MIC : 0.06 microgram/ml). Cefotiam was given intramuscularly in monotherapy, at the daily dosage of 1 and 2 g in two injections during 7 to 28 days. Followup of patients were at least 4 weeks after the end of treatment. Therapeutic results were : 15 cures and 2 failures by relapse in 17 cystitis, 6 cures and 3 failures by relapse in 9 pyelonephritis, 4 cures in 4 prostatitis. General tolerance was excellent in all cases. Intramusculary injections were well tolerated with a 2 p. cent lidocain solution. Biological tolerance and particularly renal tolerance was good in all patients.
 ...
PMID:[Clinical evaluation of cefotiam in adults urinary tract infections (author's transl)]. 628 88

Hemophilus influenzae has rarely been reported to cause urinary tract infections, but media supportive of its growth are not routinely used for urine cultures. At two Veterans Administration medical centers, H influenzae was isolated from the urine of eight men in the past four years. All had anatomic or functional genitourinary abnormalities, and half had had chronic pyelonephritis or recurrent urinary tract infections. Three patients had acute cystitis, two patients had pyelonephritis, two patients had prostatitis, and one patient had asymptomatic bacteriuria with pyuria. Cases were discovered by primary isolation on chocolate agar or sheep's blood agar, by "satelliting" around staphylococci, or by positive urine Gram's stains. Urine Gram's stains disclosed organisms in all six nonprostatitis cases. Organisms were all nonserotypable, were of biotypes 2, 3, or 4, and were beta-lactamase negative. Hemophilus influenzae may be a more common uropathogen in adults than previously recognized.
 ...
PMID:Hemophilus influenzae as a cause of urinary tract infections in men. 633 7

Ceftazidime, a new beta-lactamase resistant aminothiazo-oyl cephalosporin with a broad spectrum of antibacterial activity against gram-positive and gram-negative bacteria, including Pseudomonas species, was evaluated clinically for efficacy and safety at 3 dosage levels in patients with acute genitourinary tract infection. Sixty patients with infections, including cystitis, pyelonephritis, epididymitis and prostatitis, were assigned randomly to 1 of the 3 dosage regimens: 250, 500 or 1,000 mg. administered intramuscularly every 12 hours. Patients were evaluated bacteriologically and clinically during the course of treatment and after treatment. All patients became asymptomatic and showed clinical improvement or cure within 48 to 72 hours regardless of dosage. Bacteriological success, namely eradication of the pathogen during therapy with no recurrence of superinfection during followup, was attained in 95 per cent of the patients with uncomplicated infections and in 61 per cent of those with complicated infections. Superinfections accounted for most of the noncures, particularly with the 250 mg. regimen. The difference in success rates between the 250 mg. dosage, and the 500 mg. and 1 gm. dosages in patients with complicated infections was statistically significant. Injections were well tolerated without significant side effects. No clinically important variations in laboratory tests were observed. The results indicate that ceftazidime is a useful third generation cephalosporin for complicated and uncomplicated genitourinary infections but it is recommended that the 250 mg. dosage not be used in patients with complicated infections.
 ...
PMID:Ceftazidime, an open randomized comparison of 3 dosages for genitourinary infections. 635 Jun 16


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>